Cardinal Health (CAH) Needs CVS Renewal After Walgreen Loss - Analyst

Go back to Cardinal Health (CAH) Needs CVS Renewal After Walgreen Loss - Analyst

JPMorgan Resumes Cardinal Health (CAH) at Overweight

March 20, 2013 7:00 AM EDT

JPMorgan resumes coverage on Cardinal Health (NYSE: CAH) with a Overweight. PT $47.00.

For an analyst ratings summary and ratings history on Cardinal Health click here. For more ratings news on Cardinal Health click here.

Shares of Cardinal Health closed at $42.35 yesterday, with a 52 week range of $36.91-$47.23.... More

ISI Group Downgrades Cardinal Health (CAH) to Buy

March 20, 2013 6:59 AM EDT

ISI Group downgraded Cardinal Health (NYSE: CAH) from Strong Buy to Buy.

For an analyst ratings summary and ratings history on Cardinal Health click here. For more ratings news on Cardinal Health click here.

Shares of Cardinal Health closed at $42.35 yesterday, with a 52 week range of $36.91-$47.23.... More

Citi Downgrades Cardinal Health (CAH) to Neutral

March 20, 2013 6:59 AM EDT

Citi downgraded Cardinal Health (NYSE: CAH) from Buy to Neutral.

For an analyst ratings summary and ratings history on Cardinal Health click here. For more ratings news on Cardinal Health click here.

Shares of Cardinal Health closed at $42.35 yesterday, with a 52 week range of $36.91-$47.23.... More

Cardinal Health (CAH), Walgreen (WAG) Pharma Distribution Contract Won't be Renewed

March 19, 2013 8:51 AM EDT

Cardinal Health (NYSE: CAH) announced that its pharmaceutical distribution contract with Walgreen Co. (NYSE: WAG), which is scheduled to expire at the end of August 2013, will not be renewed.

"Although we are not yet ready to provide fiscal 2014 earnings guidance, our portfolio has considerable balance and we have prepared strategies to mitigate the impact of a Walgreens nonrenewal.... More

Cardinal Health (CAH) Slammed as AmerisourceBergen Steals Walgreen (WAG) Contract

March 19, 2013 8:47 AM EDT

Cardinal Health, Inc. (NYSE: CAH) is sharply lower early Tuesday after rival AmerisourceBergen (NYSE: ABC) won the Walgreen (NYSE: WAG), and Alliance Boots GmbH contract.

Walgreen accounted for approximately 21 percent of Cardinal Health's... More

Lazard Capital Downgrades Cardinal Health (CAH) to Neutral

March 19, 2013 8:47 AM EDT

Lazard Capital downgraded Cardinal Health (NYSE: CAH) from Buy to Neutral.

For an analyst ratings summary and ratings history on Cardinal Health click here. For more ratings news on Cardinal Health click here.

Shares of Cardinal Health closed at $46.13 yesterday, with a 52 week range of $36.91-$47.23.... More